Moreover, as shown in Fig 7C and 7D, integrated analyses of the expression of both PGM1 and FOXJ2 proteins may more precisely predict the prognosis and recurrence rate of HCC patients. The gene discussed is FOXJ2; the disease is hepatocellular carcinoma.